Cargando…

Developing Immunity Testing for SARS-CoV-2 and Other Novel Vaccines—Correlates of Immunogenicity Parameters with Protection

Detalles Bibliográficos
Autor principal:	Vajo, Zoltan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878011/ https://www.ncbi.nlm.nih.gov/pubmed/35215791 http://dx.doi.org/10.3390/v14020196

Ejemplares similares

A Reduced Dose Whole Virion Aluminum Adjuvanted Seasonal Influenza Vaccine Is Immunogenic, Safe, and Well Tolerated in Pediatric Patients †
por: Vajo, Zoltan, et al.
Publicado: (2021)

Extinction of the Influenza B Yamagata Line during the COVID Pandemic—Implications for Vaccine Composition
por: Vajo, Zoltan, et al.
Publicado: (2022)

Potential SARS-CoV-2 Immune Correlates of Protection in Infection and Vaccine Immunization
por: Sui, Yongjun, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura and other immune-mediated blood disorders following vaccination against SARS-CoV-2
por: Mannucci, Pier Mannuccio
Publicado: (2021)

Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine
por: Takano, Tomohiro, et al.
Publicado: (2022)

Immune correlates of SARS-CoV-2 protection
por: Brown, Matthew
Publicado: (2020)

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2021)

Immunogenicity of SARS-CoV-2 vaccination in rituximab-treated patients: Effect of timing and immunologic parameters()
por: Magliulo, Daniel, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection
por: Suvorov, Alexander, et al.
Publicado: (2023)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
por: Kakkassery, Helen, et al.
Publicado: (2022)

SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice
por: Tian, Jing-Hui, et al.
Publicado: (2021)

SARS-CoV-2 and other pathogenic microorganisms in the environment
por: Núñez-Delgado, Avelino, et al.
Publicado: (2021)

SARS-CoV-2: Immunopeptidomics and Other Immunological Studies
por: Chavda, Vivek P., et al.
Publicado: (2022)

Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity
por: Meyer zu Natrup, Christian, et al.
Publicado: (2022)

PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application
por: Zhang, Zhihao, et al.
Publicado: (2023)

Immunogenicity and In Vivo Protective Effects of Recombinant Nucleocapsid-Based SARS-CoV-2 Vaccine Convacell(®)
por: Rabdano, Sevastyan O., et al.
Publicado: (2023)

Baseline Gut Microbiome Signatures Correlate with Immunogenicity of SARS-CoV-2 mRNA Vaccines
por: Daddi, Lauren, et al.
Publicado: (2023)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
por: Koch, Till, et al.
Publicado: (2021)

Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants
por: Parums, Dinah V.
Publicado: (2022)

Immune correlates of protection by vaccine against SARS‐CoV‐2 in patients with chronic lymphocytic leukaemia
por: Sorcini, Daniele, et al.
Publicado: (2022)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer
por: Denault, Elyssa, et al.
Publicado: (2022)

SARS-CoV-2 vaccines: Potential refinements through induction of mucosal and trained immunity
por: Portilho, Amanda Izeli, et al.
Publicado: (2022)

Natural immunity helps overcome the age-related decline of SARS-CoV-2 vaccine immunogenicity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques
por: Yadav, Pragya D., et al.
Publicado: (2021)

Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates
por: Mukhopadhyay, Labanya, et al.
Publicado: (2021)

Immunogenicity mechanism of mRNA vaccines and their limitations in promoting adaptive protection against SARS-CoV-2
por: Salleh, Mohd Zulkifli, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
por: Hashimoto, Masayuki, et al.
Publicado: (2022)

Protection from infection or disease? Re-evaluating the broad immunogenicity of inactivated SARS-CoV-2 vaccines
por: Tan, Anthony T., et al.
Publicado: (2022)

Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine
por: Sayedahmed, Ekramy E., et al.
Publicado: (2023)

SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
por: Joyce, M. Gordon, et al.
Publicado: (2021)

Immunogenicity profiling and distinct immune response in liver transplant recipients vaccinated with SARS-CoV-2 inactivated vaccines
por: Duan, Binwei, et al.
Publicado: (2022)

Omicron and other variants of SARS-CoV-2 roles of vaccines and herd immunity in protecting from the emerging strains
por: Pustake, Manas, et al.
Publicado: (2022)

Correlation of Immunogenicity and Reactogenicity of BNT162b2 and CoronaVac SARS-CoV-2 Vaccines
por: Zhang, Ruiqi, et al.
Publicado: (2022)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

SARS-CoV2 vaccine boosters for India
por: Kang, Gagandeep
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qfu24rimcd64rrcnvceh2ugtqf